Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has a beta value of 1.94 and has seen 36,051,516 shares traded in the last trading session. The company, currently valued at $66.57 Million, closed the last trade at $8.77 per share which meant it gained $1.48 on the day or 20.22% during that session. The EKSO stock price is -127.48% off its 52-week high price of $19.95 and 74.34% above the 52-week low of $2.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 23.12 Million shares traded. The 3-month trading volume is 2.75 Million shares.

The consensus among analysts is that Ekso Bionics Holdings, Inc. (EKSO) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.55.

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) trade information

Sporting 20.22% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the EKSO stock price touched $10.74- or saw a rise of 18.34%. Year-to-date, Ekso Bionics Holdings, Inc. shares have moved 49.53%, while the 5-day performance has seen it change 156.43%. Over the past 30 days, the shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) have changed 128.39%. Short interest in the company has seen 294.17 Million shares shorted with days to cover at 106.97.

Wall Street analysts have a consensus price target for the stock at $12.5, which means that the shares’ value could jump 42.53% from current levels. The projected low price target is $12 while the price target rests at a high of $13. In that case, then, we find that the current price level is +48.23% off the targeted high while a plunge would see the stock lose 36.83% from current levels.

Ekso Bionics Holdings, Inc. (EKSO) estimates and forecasts

2 analysts offering their estimates for the company have set an average revenue estimate of $1.62 Million for the current quarter. 2 have an estimated revenue figure of $2.23 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $3.26 Million and $3.32 Million respectively for this quarter and the next, and analysts expect sales will grow by -50.3% for the current quarter and -32.8% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +43.8% over the past 5 years. Earnings growth for 2020 is a modest +61.7% while over the next 5 years, the company’s earnings are expected to increase by 0%.